Media

September 25 2025

Verismo Therapeutics Announces Partnership with Miltenyi Biotec to Support Advancing Clinical Programs

MORE >

July 29 2025

Verismo Therapeutics Named One of Philadelphia Business Journal’s 2025 Best Places to Work for Third Consecutive Year

MORE >

Scientific Poster

June 2 2025

ASCO 2025 Poster Presentation: STAR-101 Trial-in-Progress [PDF]

MORE >

May 23 2025

Verismo Therapeutics Provides Updates on Upcoming Poster Presentation at ASCO 2025

MORE >

April 24 2025

Verismo Therapeutics Announces Poster Presentation at ASCO 2025

MORE >

January 10 2025

Verismo Therapeutics Announces First Patient Infused in Phase 1 CELESTIAL-301 Clinical Trial of SynKIR™-310

MORE >

January 7 2025

Verismo Therapeutics Announces Strategic Partnership with IFLI to Support SynKIR™-310 Development in Follicular Lymphoma

MORE >

December 20 2024

Verismo Therapeutics Completes Merger to Accelerate Clinical Development

MORE >

October 8 2024

Verismo Therapeutics Announces the Activation of its CELESTIAL-301 Clinical Trial at Colorado Blood Cancer Institute

MORE >

September 17 2024

Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant

MORE >